Randomized feasibility trial of directly observed versus unobserved hepatitis C treatment with ledipasvir-sofosbuvir among people who inject drugs
2019 · PLoS ONE · 29 citations
https://doi.org/10.1371/journal.pone.0217471
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
22
Papers
799
Citations
13
h-index
15
i10-index
Emily Behar is an academic researcher from Universidade Federal da Paraíba. The author has contributed to research in topics: Opioid Use Disorder Treatment & Pain Management and Opioid Use & Substance Abuse Treatment and Outcomes. The author has an h-index of 13, co-authored 19 publications.
ORCID: 0000-0001-6200-999XClick to start Chat